Crestline Management, LP Ptc Therapeutics, Inc. Transaction History

Crestline Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$33.9 - $47.77 $1.26 Million - $1.78 Million	-37,203 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$25.7 - $47.88 $1.04 Million - $1.94 Million	-40,426 Reduced 52.08%	37,203 $1.26 Million
Q1 2018 May 15, 2018	BUY	$17.46 - $32.59 $602,527 - $1.12 Million	34,509 Added 80.03%	77,629 $2.1 Million
Q4 2017 Feb 14, 2018	SELL	$15.14 - $20.89 $69,613 - $96,052	-4,598 Reduced 9.64%	43,120 $719,000
Q3 2017 Nov 14, 2017	SELL	$16.81 - $21.61 $841,693 - $1.08 Million	-50,071 Reduced 51.2%	47,718 $955,000
Q2 2017 Aug 14, 2017	BUY	N/A	97,789	97,789 $1.79 Million

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Crestline Management, LP, based on Form 13F filings with the SEC.

Stay updated on Crestline Management, LP with notifications on news.